Hardy G - Search Results

1

Specificity of anti-human leukocyte antigen antibody responses after immunization with Remune, an inactivated HIV-1 vaccine.

Page M, Ojugo A, Imami N, Hardy G, Gotch F, Almond N. Page M, et al. Among authors: hardy g. AIDS. 2007 Jan 30;21(3):375-7. doi: 10.1097/QAD.0b013e328012b873. AIDS. 2007. PMID: 17255748 Clinical Trial.

2

Interleukin-2-associated viral breakthroughs induce HIV-1-specific CD4 T cell responses in patients on fully suppressive highly active antiretroviral therapy.

Sullivan AK, Hardy GA, Nelson MR, Gotch F, Gazzard BG, Imami N. Sullivan AK, et al. Among authors: hardy ga. AIDS. 2003 Mar 7;17(4):628-9. doi: 10.1097/00002030-200303070-00020. AIDS. 2003. PMID: 12598786

3

Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responses.

Hardy GA, Imami N, Sullivan AK, Nelson MR, Gazzard B, Gotch FM. Hardy GA, et al. AIDS. 2004 Nov 5;18(16):2199-202. doi: 10.1097/00002030-200411050-00014. AIDS. 2004. PMID: 15577655

4

Improving HIV-specific immune responses in HIV-infected patients.

Hardy GA, Imami N, Gotch FM. Hardy GA, et al. J HIV Ther. 2002 May;7(2):40-5. J HIV Ther. 2002. PMID: 12553687 Review.

5

Immune reconstitution in HIV-1-infected patients.

Imami N, Hardy G, Pires A, Burton C, Pido-Lopez J, Mela C, Gotch F. Imami N, et al. Among authors: hardy g. Curr Opin Investig Drugs. 2002 Aug;3(8):1138-45. Curr Opin Investig Drugs. 2002. PMID: 12211404 Review.

6

Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune).

Pido-Lopez J, Burton C, Hardy G, Pires A, Sullivan A, Gazzard B, Aspinall R, Gotch F, Imami N. Pido-Lopez J, et al. Among authors: hardy g. AIDS Res Hum Retroviruses. 2003 Feb;19(2):103-9. doi: 10.1089/088922203762688603. AIDS Res Hum Retroviruses. 2003. PMID: 12639245

7

Therapeutic vaccines in HIV.1 infection.

Gotch F, Hardy G, Imami N. Gotch F, et al. Among authors: hardy g. Immunol Rev. 1999 Aug;170:173-82. doi: 10.1111/j.1600-065x.1999.tb01337.x. Immunol Rev. 1999. PMID: 10566150 Review.

8

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination.

Imami N, Hardy G, Burton C, Pires A, Pido-Lopez J, Moss R, Gazzard B, Gotch F. Imami N, et al. Among authors: hardy g. Immunol Lett. 2001 Nov 1;79(1-2):63-76. doi: 10.1016/s0165-2478(01)00267-x. Immunol Lett. 2001. PMID: 11595291

9

Development of immunotherapeutic strategies for HIV-1.

Imami N, Hardy G, Gotch F. Imami N, et al. Among authors: hardy g. Expert Opin Biol Ther. 2001 Sep;1(5):803-16. doi: 10.1517/14712598.1.5.803. Expert Opin Biol Ther. 2001. PMID: 11728216 Review.

10

Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipients.

Imami N, Hardy G, Pires A, Burton C, Sullivan A, Gotch F. Imami N, et al. Among authors: hardy g. HIV Med. 2001 Jul;2(3):146-53. doi: 10.1046/j.1468-1293.2001.00068.x. HIV Med. 2001. PMID: 11737394 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters